Dirix LY - Search Results

1

The rationale for mTOR inhibition in epithelial ovarian cancer.

Trinh XB, van Dam PA, Dirix LY, Vermeulen PB, Tjalma WA. Trinh XB, et al. Among authors: dirix ly. Expert Opin Investig Drugs. 2009 Dec;18(12):1885-91. doi: 10.1517/13543780903321508. Expert Opin Investig Drugs. 2009. PMID: 19888868 Review.

2

Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma.

Dirix LY, Prove A, Becquart D, Wouters E, Vermeulen P, Van Oosterom A. Dirix LY, et al. Cancer. 1991 Apr 15;67(8):2207-10. doi: 10.1002/1097-0142(19910415)67:8<2207::aid-cncr2820670834>3.0.co;2-r. Cancer. 1991. PMID: 2004341

3

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.

Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Vermeulen PB, et al. Among authors: dirix ly. Br J Cancer. 1995 Feb;71(2):340-3. doi: 10.1038/bjc.1995.68. Br J Cancer. 1995. PMID: 7530985 Free PMC article.

4

Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas.

Vermeulen PB, Verhoeven D, Hubens G, Van Marck E, Goovaerts G, Huyghe M, De Bruijn EA, Van Oosterom AT, Dirix LY. Vermeulen PB, et al. Among authors: dirix ly. Ann Oncol. 1995 Jan;6(1):59-64. doi: 10.1093/oxfordjournals.annonc.a059043. Ann Oncol. 1995. PMID: 7536030 Free article.

5

5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.

Vermeulen PB, Dirix LY, Pelgrims G, Van Oosterom AT. Vermeulen PB, et al. Among authors: dirix ly. Cancer. 1995 Aug 1;76(3):528-30. doi: 10.1002/1097-0142(19950801)76:3<528::aid-cncr2820760327>3.0.co;2-w. Cancer. 1995. PMID: 8625138 Clinical Trial. No abstract available.

6

Microvascular count and prognosis in colorectal cancer.

Dirix LY, Vermeulen PB, Van Oosterom AT, Gasparini G. Dirix LY, et al. J Clin Oncol. 1996 Aug;14(8):2400-3. doi: 10.1200/JCO.1996.14.8.2400. J Clin Oncol. 1996. PMID: 8708734 No abstract available.

7

Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors--an antiangiogenic effect?

Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom AT. Dirix LY, et al. Anticancer Drugs. 1996 Feb;7(2):175-81. doi: 10.1097/00001813-199602000-00005. Anticancer Drugs. 1996. PMID: 8740722 Clinical Trial.

8

Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma.

Vermeulen PB, Roland L, Mertens V, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Vermeulen PB, et al. Among authors: dirix ly. Microvasc Res. 1996 Mar;51(2):164-74. doi: 10.1006/mvre.1996.0018. Microvasc Res. 1996. PMID: 8778572

9

High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group.

Vermeulen PB, Dirix LY, Van Marck E, Van Oosterom AT. Vermeulen PB, et al. Among authors: dirix ly. Br J Cancer. 1996 Nov;74(9):1506-7. doi: 10.1038/bjc.1996.574. Br J Cancer. 1996. PMID: 8912554 Free PMC article. No abstract available.

10

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer.

Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooter C, Van Oosterom AT. Dirix LY, et al. Ann Oncol. 1996 Oct;7(8):843-8. doi: 10.1093/oxfordjournals.annonc.a010764. Ann Oncol. 1996. PMID: 8922199 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters